Alnylam Pharmaceuticals, Inc. (ALNY)

359.13 -7.73 (-2.11%) USD  |  NASDAQ  |  Jan 15, 16:00
359.13 0.00 (0.00%) After-Hours: 16:49
More

Alnylam Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Biogen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
BridgeBio Pharma, Inc. Upgrade